Intensity Therapeutics, Inc.
INTS • NASDAQ
Intensity Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Lewis H. Bender, with a market cap of $15.3M.
CEOLewis H. Bender
Next Earnings
Upcoming earnings announcement for Intensity Therapeutics, Inc.
Date
Tuesday, May 12, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$1.43
Earnings History
Past 11 earnings reports for Intensity Therapeutics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 27, 2026 | Q4 2025 | -$1.31Est: -$1.29 | -1.6% | - | — |  10-K |
| Nov 6, 2025 | Q3 2025 | -$0.06Est: -$0.06 | 0.0% | - | — | 10-Q |
| Aug 7, 2025 | Q2 2025 | -$0.13Est: -$0.18 | +27.8% | - | — | 10-Q |
| May 13, 2025 | Q1 2025 | -$0.22Est: -$0.13 | -69.2% | - | — | 10-Q |
| Mar 13, 2025 | Q4 2024 | -$0.22Est: -$0.23 | +4.3% | - | — | 10-K |
| Nov 13, 2024 | Q3 2024 | -$0.25Est: -$0.30 | +16.7% | - | — | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$0.36Est: -$0.32 | -12.5% | - | — | 10-Q |
| May 9, 2024 | Q1 2024 | -$0.34 | — | - | — | 10-Q |
| Mar 14, 2024 | Q4 2023 | -$0.12Est: -$0.18 | +33.3% | - | — | 10-K |
| Nov 13, 2023 | Q3 2023 | -$0.17Est: -$0.09 | -88.9% | - | — | — |
| Aug 14, 2023 | Q2 2023 | -$0.79Est: -$0.40 | -97.5% | - | — | 10-Q |